Nephrology
Nephrology
The National Kidney Foundation states that IgA nephropathy often occurs in people between 20 and 40 years old who are otherwise healthy. Risk factors for developing IgAN include having high blood pressure or diabetes, a family history of IgAN, and having had a kidney transplant. Other rarer risk factors include infections by bacteria such as “Mycoplasma pneumoniae”, viruses such as polio and rubella, and drugs such as penicillin and methicillin.
IgAN is diagnosed by a series of blood and urine tests that measure the amounts of protein and creatinine in the body fluids. There are no specific lab tests for IgAN, so your doctor might also recommend imaging and/or an examination of the kidneys to diagnose IgAN.
Royal research is looking for volunteers to take part in a trial testing an experimental new medicine to see if it can treat IgAN. In a clinical trial in China, this experimental novel medication showed promise in treating IgAN by lowering urine protein levels. More clinical evidence is needed, however, to fully assess Telitacicept’s efficacy and safety in IgAN patients.
Frequently Asked Questions.
Nephrology is the study of the kidney and diseases that affect them. This includes management of renal replacement therapy (dialysis and transplantation), systemic diseases that affect the kidney (such as diabetes and hypertension) as well as autoimmune diseases (such as Lupus).
Patients may notice some of the following: tiredness and less energy; trouble concentrating; poor appetite; trouble sleeping; muscle cramping at night; swollen feet and ankles; puffiness around the eyes especially in the morning; dry, itchy skin; and frequent urination, especially at night.
